Products

inHEART Models
inHEART
Cardiology AI
inHEART Models is an AI-driven software that creates detailed 3D digital twin models of the heart from CT/MR images, optimizing planning and execution of image-guided cardiac ablation procedures.

See all 1 product →

About inHEART

inHEART is a deep tech healthcare company that has developed an AI-driven, cloud-based software solution to create highly detailed 3D digital twins of the heart from medical images (CT and MR) and ECG data. This technology is designed to assist cardiologists and electrophysiologists in the personalized treatment, prevention, and screening of various cardiac conditions, including arrhythmias, heart failure, sudden cardiac death, and cardio-embolic stroke. The software provides unprecedented anatomical details of tissue and structural characteristics, including precise descriptions of arrhythmogenic areas in scar tissue, which are crucial for complex cases like ventricular tachycardia (VT).

The inHEART solution aims to optimize treatment strategies by enabling physicians to plan ablation procedures outside the lab, thereby reducing procedure times, simplifying strategies, and improving precision and safety. The 3D models integrate seamlessly into electroanatomic mapping (EAM) systems for use during procedures. The company’s technology has been utilized with thousands of patients across numerous medical centers worldwide, and it has received regulatory clearances including FDA 510(k) clearance in the U.S. and CE certification for the European market.

Focus Areas

Cardiac Imaging Cardiac Electrophysiology AI-enabled Digital Twin Medical Image Analysis Cardiac Modeling Therapy Planning Software Heart Rhythm Disorders Advanced Visualization Simulation Software

Business Intelligence

TechnologyAI-driven, cloud-based software solution that transforms preoperative medical images (CT and/or MR) and ECG data into 3D digital twins of the heart using proprietary segmentation algorithms.

What Physicians Need to Know

Specialization: Cardiac Arrhythmias & VT Ablation
inHEART specializes in treating complex cardiac arrhythmias, particularly Ventricular Tachycardia (VT), through advanced image-guided ablation procedures. Their technology aims to improve the efficacy and efficiency of these procedures.
Key Differentiator: AI-Powered 3D Cardiac Digital Twin
inHEART's core differentiator is its AI-powered software that transforms pre-operative CT and MRI images into highly detailed, interactive 3D digital twins of a patient's heart. This digital twin provides unprecedented anatomical details, including tissue characteristics, scar tissue, and structural information, which are crucial for precise ablation planning.
Technology Stack: Cloud-Based AI Software & Image Segmentation
Their technology stack includes a cloud-based medical imaging and AI software solution. It utilizes proprietary AI segmentation algorithms to analyze CT/MR images and ECG data, generating the 3D cardiac models.
Focus: Pre-Procedural Planning & Intraprocedural Guidance
The inHEART solution is designed for both pre-procedural planning and intraprocedural guidance, allowing physicians to optimize treatment strategies outside the lab and then seamlessly integrate the 3D models into electroanatomic mapping (EAM) systems during the procedure.
Future Development: Predictive Cardiac Models
Beyond current therapeutic solutions, inHEART is actively developing AI-driven predictive software models for conditions such as heart failure, sudden cardiac death, and cardio-embolic stroke, aiming to expand their impact across the cardiac care continuum.
Physician Tip

For physicians, inHEART offers a significant advantage by providing highly detailed, patient-specific 3D cardiac models derived from CT and MR images. This allows for optimized pre-procedural planning, potentially reducing procedure times by up to 60% and improving success rates by 15% for VT ablations. The ability to visualize arrhythmogenic areas, scar tissue, and unique anatomical details with precision helps in targeting ablation strategies more effectively, especially in complex cases. The seamless integration with major electroanatomic mapping systems ensures that this detailed information is available during the procedure, enabling more focused and efficient therapy delivery. Furthermore, the cloud-based platform facilitates collaboration and sharing of images with colleagues for optimal strategy definition. Early clinical evaluations and studies suggest reduced VT recurrence rates with inHEART-guided ablations.

inHEART's solution is designed for seamless integration with all major electroanatomic mapping (EAM) systems, allowing physicians to utilize the detailed 3D cardiac models directly during ablation procedures. The company also has a global distribution agreement with Circle Cardiovascular Imaging Inc., enabling broader access to their AI-driven digital twin of the heart through Circle's worldwide sales network.

Products by inHEART

1 product in the directory

inHEART Models
inHEART
Cardiology AI
inHEART Models is an AI-driven software that creates detailed 3D digital twin models of the heart from CT/MR images, optimizing planning and execution of image-guided cardiac ablation procedures.

What the Web Says

inHEART is a medical device company specializing in AI-enabled digital twins of the heart, aiming to revolutionize cardiac care, particularly for arrhythmias. Their technology generates detailed 3D cardiac models from CT and MRI images, providing insights for optimized treatment strategies. The company's software, inHEART Models, has received FDA clearance and is used in over 50 centers worldwide. While there are many positive indicators for their product, specific user reviews on platforms like G2, Glassdoor, Capterra, and Reddit are limited or not directly available for "inHEART" as a distinct entity, often conflated with other companies containing "inHealth" or similar names.

Overall: Positive

Strengths

  • Provides highly detailed 3D cardiac models for in-depth anatomical insights.
  • Enhances precision and optimizes treatment strategies for heart diseases, especially arrhythmias.
  • Reduces procedure time and improves success rates in cardiac ablation procedures.
  • Features a user-friendly and intuitive interface.
  • Seamlessly integrates with major electroanatomic mapping (EAM) systems.
  • Empowers physicians with data-driven decisions.

Limitations

  • Limited direct product and employer reviews available on major review platforms (G2, Glassdoor, Capterra, Reddit) specifically for "inHEART".
  • Potential for confusion with similarly named companies (e.g., InHealth, InHealth Systems & Services) which have mixed to negative employer reviews.
  • The cost-effectiveness, while cited as a pro, may still be a consideration for wider adoption, and larger storage space may be needed.

Based on reviews from: inHEART Medical Website, Vertex AI Search, Indeed.com, FantAstrial, ResearchGate, Medical Product Outsourcing, G2, Reddit, Capterra, Trustpilot

Last updated: 2026-10-23

Videos

News, demos, and interviews about inHEART.

Loading videos...

Videos load interactively. If none appear, search YouTube for inHEART →

View all on YouTube

Press & Coverage

PR Newswire
inHEART Receives FDA Clearance For Advanced AI-Driven Software Module That Optimizes the Creation of 3D Models of the Heart
inHEART announced FDA 510(k) clearance for its AI software module, enabling fully automated segmentation of CT images for 3D cardiac models, improving speed and efficiency for physicians.
2024-03
PR Newswire
inHEART Raises $11M To Accelerate Development & Deployment of Novel Therapeutic, Predictive, and Screening Cardiac Solutions
inHEART secured $11M in funding to expand its therapeutic software for cardiac ablation and advance predictive cardiac models for heart failure, sudden cardiac death, and cardio-embolic stroke.
2024-05
EIT - European Union
inHEART secures USD 11 million to optimise cardiac care
EIT Health-supported startup inHEART raised $11 million to boost commercial growth of its AI-driven software for cardiac ablation procedures and develop advanced 3D cardiac models.
2024-05
LSI Medtech
Medtech Companies to Watch: InHeart Raises $11M to Transform Cardiac Care
InHeart secured $11 million to accelerate the development and deployment of its innovative therapeutic and predictive cardiac solutions, enhancing its digital twin cardiac modeling technology.
2024-05
inHEART
inHEART Receives FDA Clearance for Novel 3D Cardiac Modeling Solution
inHEART received FDA 510(k) clearance for its inHEART MODELS software suite, enabling 3D visualization and analysis of anatomical structures for pre-procedural planning and intraprocedural use in cardiac ablations.
2022-05
inHEART
inHEART Selected to Participate in Groundbreaking French Consortium to Advance Digital Twins in Healthcare
inHEART was selected for the MEDITWIN consortium, a multidisciplinary effort in France to evaluate and accelerate the use of personalized digital twins to improve patient care in neurology, cardiology, and oncology.
2024-01
inHEART
inHEART closes 750k€ funding with SWEN Capital Partners
inHEART successfully closed a 750k€ funding round with SWEN Capital Partners, accelerating the development of its imaging platform for diagnosing and treating complex heart rhythm disorders.
2024-10
inHEART
inHEART Appoints Todor Jeliaskov as New CEO
inHEART appointed Todor Jeliaskov as CEO to lead the company's mission to bridge the gap between cardiology and medical imaging with a digital twin of the patient's heart.
2021-10

Frequently Asked Questions

inHEART's technology primarily focuses on complex cardiac arrhythmias, particularly Ventricular Tachycardia (VT). It aims to improve VT ablation procedures by providing highly detailed 3D cardiac models and a digital twin of the heart, enabling more precise and effective image-guided ablations. This precision helps reduce procedure times and recurrence rates by identifying critical ablation targets more accurately.
inHEART's 3D cardiac modeling and digital twin technology are designed to integrate seamlessly with existing clinical workflows. It processes standard medical images (e.g., CT, MRI) to create personalized 3D cardiac models, which can then be used with common electrophysiology mapping systems. This integration allows for pre-procedural planning and real-time guidance during image-guided cardiac ablations.
Clinical studies and ongoing research demonstrate the efficacy of inHEART's technology in improving VT ablation outcomes, which can indirectly impact heart failure management and reduce the risk of sudden cardiac death. By enabling more precise ablations, the technology aims to reduce arrhythmia recurrence, a key factor in these conditions. Specific data on direct impact on heart failure progression or sudden cardiac death reduction would be available through their clinical evidence and publications.
inHEART's pricing and reimbursement models are typically structured to align with the value proposition of improved procedural efficiency and patient outcomes. Specific details on pricing and reimbursement would be provided directly by inHEART, often varying by region and healthcare system. The company offers comprehensive technical support and training programs to ensure clinicians can effectively integrate and utilize their technology.
inHEART prioritizes data privacy, cybersecurity, and regulatory compliance by adhering to stringent standards such as GDPR, HIPAA, and FDA regulations. Their AI algorithms are developed with a focus on data security and patient confidentiality, employing robust encryption and anonymization techniques. The company ensures that its products undergo rigorous validation and regulatory approval processes to meet the highest safety and efficacy standards.

Related Companies

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]

Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]

CortiCare is a healthcare AI company specializing in neuro telemetry and remote patient monitoring, primarily focusing on electroencephalogram (EEG) services. The company provides telehealth services and an EEG brain monitoring platform to neurology and critical care areas within hospitals, including ICUs, NICUs, PICUs, and EMUs. Their services aim to enhance the neurological assessment of adult, […]

CapsoVision is a commercial-stage medical technology company that develops advanced imaging and artificial intelligence (AI) technologies for capsule endoscopy solutions. Their primary goal is to identify abnormalities of the gastrointestinal (GI) tract for diagnostic and screening purposes. [7] Their flagship product, the CapsoCam Plus system, is a single-use capsule endoscope equipped with four cameras, providing […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.